Gram Research analysis of a 2026 PeerJ study found that two natural plant compounds, quillaic acid and echinocystic acid, reduced artery plaque in mice fed a high-fat diet. At 5 mg/kg, both lowered blood fats and inflammation, with echinocystic acid working slightly better. The findings come from lab and animal work and have not yet been tested in humans.
Heart disease often starts when fatty deposits build up inside artery walls, a process called atherosclerosis. A new study published in PeerJ in 2026 tested two natural plant compounds, quillaic acid and echinocystic acid, to see whether they could slow this process. According to research reviewed by Gram, laboratory tests showed that both compounds reduced the formation of fat-filled cells and calmed inflammation. In genetically modified mice fed a high-fat, high-cholesterol diet, both compounds lowered blood fats, reduced inflammatory signals, and produced less plaque in the arteries. Echinocystic acid worked slightly better at the dose tested. The researchers also found changes in genes tied to the body’s daily clock and to blood vessel relaxation. These results are early and come from cells and animals, so they cannot yet show whether people would benefit in the same way.
Key Statistics
A 2026 study published in PeerJ found that quillaic acid and echinocystic acid both reduced plaque formation in ApoE knockout mice fed a high-fat, high-cholesterol diet at a dose of 5 mg/kg.
In the same 2026 PeerJ study, echinocystic acid showed slightly better anti-inflammatory and plaque-reducing effects than quillaic acid at the 5 mg/kg dose tested in mice.
The 2026 PeerJ research reported that echinocystic acid increased cGMP levels in fat-filled immune cells grown in the laboratory, a signal linked to blood vessel relaxation.
The Quick Take
- What they studied: Scientists wanted to know whether two natural plant compounds, quillaic acid and echinocystic acid, could reduce the buildup of fatty plaque in arteries, which can lead to heart attacks and strokes.
- Who participated: The study used cells grown in a laboratory dish and genetically modified mice that are prone to clogged arteries. The exact number of mice was not listed in the summary provided, so the total sample size is unclear.
- Key finding: Both compounds reduced fat buildup in cells, calmed inflammation, lowered blood fats, and shrank plaque in mice fed a high-fat diet. Echinocystic acid performed slightly better than quillaic acid at the dose tested, which was 5 mg/kg of body weight.
- What it means for you: These results are promising but early. The compounds have not been tested in people, so they should not be used as a treatment. Heart-healthy habits such as eating more vegetables, staying active, and managing cholesterol with your doctor remain the proven approach.
The Research Details
The research had two main parts. First, scientists exposed immune cells to a form of cholesterol that is known to cause fat-filled cells to build up, which is an early step in plaque formation. They then tested whether quillaic acid and echinocystic acid could block this fat buildup and reduce inflammation caused by a bacterial substance called LPS.
Second, the team tested the compounds in mice that lack a gene called ApoE, which makes them prone to clogged arteries. The mice ate a diet high in fat and cholesterol, and some received the compounds by injection at 5 mg/kg. The researchers then measured blood fats, inflammatory markers, and plaque size in the arteries.
The team also used gene activity tests on the aorta, the body’s main artery, and the liver. These tests showed which biological pathways changed when the compounds were given, helping explain how they might work.
Testing in cells shows whether a compound has a direct effect on the cells involved in plaque formation. Testing in animals then shows whether that effect appears in a living body with a complex system of organs, blood, and immune responses. Using both approaches together makes the early evidence more convincing than either one alone.
The study was published in PeerJ, a peer-reviewed journal, which means other experts reviewed it before publication. It used multiple methods, including cell experiments, animal testing, and gene analysis, which supports the findings. However, the summary does not clearly state the number of mice or cells used, the length of treatment, or the statistical details, so readers cannot fully judge the strength of the results. Animal studies also do not always translate to humans.
What the Results Show
In laboratory cells, both quillaic acid and echinocystic acid reduced the buildup of fat inside immune cells that normally turn into the fatty core of artery plaque. The compounds appeared to work by limiting how much cholesterol these cells took in. Both compounds also reduced inflammation triggered by a bacterial substance, suggesting they can calm the immune response that drives artery damage.
In mice fed a high-fat, high-cholesterol diet, both compounds lowered blood fat levels and reduced the release of inflammatory signals. The mice treated with either compound also developed less plaque in their arteries compared with untreated mice. These changes point toward a protective effect on the blood vessels rather than just a change in one blood marker.
At the dose tested, echinocystic acid appeared to be slightly more effective than quillaic acid at reducing inflammation and plaque. The word slightly matters here, because the difference was described as modest, and it may not hold at other doses.
Gene analysis revealed that quillaic acid affected genes involved in cell adhesion, which helps immune cells stick to artery walls, and in immune responses. Echinocystic acid affected genes tied to daily body rhythms in the liver and aorta, and to the relaxation and contraction of blood vessel muscle. In the lab, echinocystic acid also raised levels of a signaling molecule called cGMP, which helps blood vessels relax.
The researchers found that echinocystic acid changed the activity of circadian rhythm genes, which control the body’s internal clock. Changes in these genes were confirmed in both the liver of treated mice and in the fat-filled cells grown in the lab. This is an interesting new idea, because the body’s clock is known to influence heart health, but the practical meaning of this finding is still unclear.
The increase in cGMP in cells treated with echinocystic acid is also significant. cGMP is linked to blood vessel relaxation and blood pressure control, so this result offers a possible second pathway by which the compound might protect arteries.
Many natural compounds found in plants have been studied for their anti-inflammatory and cholesterol-lowering effects, and several have shown promise in animal studies. This paper describes itself as the first to test quillaic acid and echinocystic acid specifically for atherosclerosis, so it adds a new candidate to a growing list. It fits with broader research showing that calming inflammation is an important part of protecting arteries, not just lowering cholesterol.
The most important limitation is that this research was done in cells and in mice, not in people. Mice are useful models, but human arteries, diets, and immune systems differ in important ways. The mice also had a genetic change that makes them prone to plaque, so results may not apply to typical human heart disease.
The study tested only one dose of each compound, so it is not clear whether higher or lower doses would work better or cause side effects. The summary also does not describe how long the treatment lasted, the exact number of animals, or the safety of long-term use. Finally, the gene analysis shows which pathways changed, but it does not prove that these changes directly cause the reduction in plaque.
The Bottom Line
Based on this early research, quillaic acid and echinocystic acid show promise for further study as possible plaque-reducing compounds. Confidence that they would help people is currently low, because no human trials were reported. Proven steps for artery health, such as eating a diet rich in vegetables, whole grains, and healthy fats, staying physically active, avoiding smoking, and managing blood pressure and cholesterol with a doctor, remain the strongest evidence-based advice.
People with heart disease risk factors, researchers who study cardiovascular health, and anyone interested in the potential of plant-based medicines may find this study useful. People who are taking cholesterol or blood pressure medication should not change or add supplements based on this research without talking to their doctor. Pregnant women, people with kidney or liver problems, and those taking blood thinners should be especially careful with any new supplement.
Human benefits from these compounds are not yet known, and it may take years of laboratory work and clinical trials before any treatment could be considered. Even if the compounds prove useful, the process from animal research to approved medicine is typically long. Anyone looking to improve artery health right now should expect changes from diet, activity, and medical care to build up over months, not days.
Frequently Asked Questions
Can quillaic acid or echinocystic acid help clear clogged arteries in people?
Not yet proven. A 2026 PeerJ study showed both compounds reduced artery plaque in mice and in lab cells, but no human trials were reported. Research in animals does not always translate to people, so more clinical testing would be needed before any use is recommended.
What is echinocystic acid and where does it come from?
Echinocystic acid is a natural pentacyclic triterpene, a type of compound found in certain plants. In a 2026 PeerJ study, it reduced inflammation and plaque formation in mice at 5 mg/kg, performing slightly better than the related compound quillaic acid at that dose.
How does atherosclerosis cause heart problems?
Atherosclerosis happens when fatty deposits, called plaque, build up inside artery walls. Over time, plaque narrows arteries and can rupture, which may cause heart attacks or strokes. Research published in PeerJ in 2026 studied natural compounds that may slow this process in animal models.
What are proven ways to protect my arteries right now?
Eating plenty of vegetables, fruits, and whole grains, staying physically active, avoiding smoking, and managing blood pressure and cholesterol with a doctor are well-supported steps. These habits have far stronger evidence in people than any plant compound tested so far in animal studies.
Want to Apply This Research?
- Track daily servings of vegetables, fruits, and whole grains, along with minutes of physical activity, and log your weekly blood pressure and cholesterol readings if your doctor has recommended monitoring them. Record these numbers in the app so you can see trends over time.
- Set a small, realistic goal such as adding one extra serving of vegetables to lunch or dinner each day, or walking for 10 minutes after a meal. The app can send reminders and show progress so the habit becomes automatic. If you are curious about plant compounds, discuss them with your doctor before adding any supplement.
- Review your logged habits and health readings every month to spot patterns, such as whether higher activity lines up with better blood pressure readings. Share the summary with your doctor at regular checkups. Update your goals as your health needs change, and keep a note of any new research or treatments you discuss with your care team.
This article summarizes an early-stage study conducted in laboratory cells and in mice. The compounds described have not been tested for safety or effectiveness in humans and are not approved as treatments for heart disease. Do not start, stop, or change any medication or supplement based on this research without first speaking with your doctor or other qualified healthcare provider.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.